Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCR9 | P51686 | 4/20 | 0.53 |
| ▸ | FBP1 | P09467 | 1/20 | 0.53 |
| ▸ | FFAR4 | Q5NUL3 | 2/20 | 0.52 |
| ▸ | LMNA | P02545 | 2/20 | 0.51 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.47 |
| ▸ | TP53 | P04637 | 2/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | GAA | P10253 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | HTT | P42858 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.47 |
| ▸ | CCR2 | P41597 | 3/20 | 0.46 |
| ▸ | HSD17B2 | P37059 | 2/20 | 0.44 |
| ▸ | PTGDR2 | Q9Y5Y4 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26537124 | 0.83 | LMNA (0.62) | CCR9FBP1FFAR4LMNAALDH1A1 | |
| SCHEMBL26537032 | 0.82 | LMNA (0.77) | CCR9FBP1FFAR4LMNAALDH1A1 | |
| SCHEMBL26536592 | 0.81 | LMNA (0.66) | CCR9FBP1FFAR4LMNAALDH1A1 | |
| SCHEMBL26537109 | 0.81 | FFAR4 (0.56) | CCR9FBP1FFAR4LMNAGAA | |
| SCHEMBL26537094 | 0.79 | SLC22A12 (0.57) | CCR9FBP1FFAR4LMNAALDH1A1 | |
| SCHEMBL26537047 | 0.78 | LMNA (0.57) | CCR9FBP1FFAR4LMNAALDH1A1 | |
| SCHEMBL7570765 | 0.75 | CES1 (0.67) | FBP1FFAR4ALDH1A1TP53MAPT | |
| SCHEMBL7591561 | 0.75 | FFAR4 (0.64) | CCR9FBP1FFAR4LMNAALDH1A1 | |
| SCHEMBL14458175 | 0.74 | ALOX15 (0.64) | CCR9FBP1FFAR4ALDH1A1MEN1 | |
| SCHEMBL29087421 | 0.73 | KMT2A (0.64) | CCR9FBP1FFAR4MEN1GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230322715-A1 | BROAD SPECTRUM ANTI-CANCER COMPOUNDS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2023-10-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230322715-A1 | BROAD SPECTRUM ANTI-CANCER COMPOUNDS | YTHDF1, YTHDF3, YTHDF2 | CCR9 2746/4885FBP1 2982/4885FFAR4 2391/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.